BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17371940)

  • 1. Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance.
    Izawa T; Ishimaru N; Moriyama K; Kohashi M; Arakaki R; Hayashi Y
    Blood; 2007 Jul; 110(1):242-50. PubMed ID: 17371940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
    Izawa T; Kondo T; Kurosawa M; Oura R; Matsumoto K; Tanaka E; Yamada A; Arakaki R; Kudo Y; Hayashi Y; Ishimaru N
    PLoS One; 2012; 7(12):e48798. PubMed ID: 23300516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/S1P
    Hutami IR; Izawa T; Mino-Oka A; Shinohara T; Mori H; Iwasa A; Tanaka E
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1274-1281. PubMed ID: 28687489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
    Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
    Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis mediated by fas receptor and activation of caspase-3 in MRL-+/+ or MRL-lpr/lpr murine oocytes.
    Guo M; Sato E; Li X; Mori E; Saito S; Mori T
    Zygote; 2002 Feb; 10(1):17-22. PubMed ID: 11964087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas Signaling in Dendritic Cells Mediates Th2 Polarization in HDM-Induced Allergic Pulmonary Inflammation.
    Han M; Hu R; Ma J; Zhang B; Chen C; Li H; Yang J; Huang G
    Front Immunol; 2018; 9():3045. PubMed ID: 30619373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
    Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
    J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines.
    Guo Z; Zhang M; Tang H; Cao X
    Blood; 2005 Sep; 106(6):2033-41. PubMed ID: 15941911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation.
    Wu L; Luo Z; Liu Y; Jia L; Jiang Y; Du J; Guo L; Bai Y; Liu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):375. PubMed ID: 31805984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligation induces IL-1beta-dependent maturation and IL-1beta-independent survival of dendritic cells: different roles of ERK and NF-kappaB signaling pathways.
    Guo Z; Zhang M; An H; Chen W; Liu S; Guo J; Yu Y; Cao X
    Blood; 2003 Dec; 102(13):4441-7. PubMed ID: 12920043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
    Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
    J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation.
    Zielinski CE; Jacob SN; Bouzahzah F; Ehrlich BE; Craft J
    J Immunol; 2005 Apr; 174(8):5100-9. PubMed ID: 15814741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y; Chen K; Sharp GC; Braley-Mullen H
    J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
    Wu H; Lo Y; Chan A; Law KS; Mok MY
    Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
    Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
    J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
    Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
    J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.
    Klenner L; Hafezi W; Clausen BE; Lorentzen EU; Luger TA; Beissert S; Kühn JE; Loser K
    J Invest Dermatol; 2015 Nov; 135(11):2676-2687. PubMed ID: 26076314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.